#SFHS2616124VPrice notice for Evrysdi 5 mg Roche tablets
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This notice sets the reimbursement tariff and maximum sale price for Evrysdi 5 mg film-coated tablets supplied by Roche to French healthcare establishments at €614.141 excluding tax per UCD unit.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets the reimbursement tariff for Evrysdi 5 mg tablets at €614.141 excluding tax per UCD unit
- Sets the maximum sale price to healthcare establishments at the same amount
- Applies to the Roche product identified under UCD code 34008 900 493 7 5
Obligations
What this law requires
medium
For EVRYSDI 5 mg film-coated tablets supplied under UCD code 3400890049375, the maximum sale price to French healthcare establishments is set at €614.141 excluding tax per UCD unit.
pharmaceutical laboratory or supplier selling the listed specialty to healthcare establishments
operational
medium
For EVRYSDI 5 mg film-coated tablets under UCD code 3400890049375, the reimbursement tariff is set at €614.141 excluding tax per UCD unit.
French healthcare establishments and reimbursement/payment bodies applying the listed tariff
operational
Affected Parties
French healthcare establishmentsRoche SA+1 more…
Tags
pharmaceutical-pricing,reimbursement,hospital-medicines